title: Mutation of CDKN2 is infrequently detected in myelodysplastic syndrome.
authors.forename: H
authors.initials: H
authors.lastname: Kaneko
authors.forename: S
authors.initials: S
authors.lastname: Horiike
authors.forename: M
authors.initials: M
authors.lastname: Nakao
authors.forename: S
authors.initials: S
authors.lastname: Yokota
authors.forename: Y
authors.initials: Y
authors.lastname: Sasai
authors.forename: T
authors.initials: T
authors.lastname: Iwai
authors.forename: H
authors.initials: H
authors.lastname: Nakagawa
authors.forename: H
authors.initials: H
authors.lastname: Fujii
authors.forename: M
authors.initials: M
authors.lastname: Taniwaki
authors.forename: K
authors.initials: K
authors.lastname: Kashima
authors.forename: S
authors.initials: S
authors.lastname: Misawa
mesh_terms: D002352:Carrier Proteins / Q000235:genetics*; D002453:Cell Cycle; D019941:Cyclin-Dependent Kinase Inhibitor p16; D006801:Humans; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000235:genetics*; D018807:Polymorphism, Single-Stranded Conformational; D017384:Sequence Deletion; D016159:Tumor Suppressor Protein p53 / Q000235:genetics
chemical_list: D002352:Carrier Proteins; D019941:Cyclin-Dependent Kinase Inhibitor p16; D016159:Tumor Suppressor Protein p53